|Articles|June 1, 2019
- Pharmaceutical Executive-06-01-2019
- Volume 39
- Issue 6
Pharmaceutical Executive, June 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive June 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
Pharm Exec's Top 50 Companies 2019over 6 years ago
The Argument for External Comparator Adoptionover 6 years ago
Pharma Medical Affairs: A Blueprint for Futureover 6 years ago
'Vision’ Quest: Leading Through Changeover 6 years ago
Pharm Exec 50 Hints to Rest of ’19over 6 years ago
Predicting the Future of European Health Policyover 6 years ago
A Critical Juncture for Antibiotic R&Dover 6 years ago
New Strategies Sought to Pay for Costly Curesover 6 years ago
Site Payments: Drilling in on Forecast, Budget Issuesover 6 years ago
Building the Startup Dream TeamNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Pfizer Files Lawsuits Against Metsera and Novo Nordisk
2
FDA Approves Kygevvi Becoming the First Treatment for Thymidine Kinase 2 Deficiency
3
Join Us Tonight: Inside Trump’s Drug Price Plan
4
Roundup: Biotech’s Most Recent Strategic Partnerships and Exclusive Licensing Agreements
5
